{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:08:03Z","timestamp":1790255283257,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25lk0221213"],"award-info":[{"award-number":["JP25lk0221213"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23ek0109512"],"award-info":[{"award-number":["JP23ek0109512"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["22KK0136"],"award-info":[{"award-number":["22KK0136"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["22H03242"],"award-info":[{"award-number":["22H03242"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020050","name":"Japan Intractable Diseases Research Foundation","doi-asserted-by":"publisher","award":["2020C01"],"award-info":[{"award-number":["2020C01"]}],"id":[{"id":"10.13039\/100020050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.xops.2026.101381","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:10:48Z","timestamp":1787670648000},"page":"101381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inflammatory Markers and Disease Progression in Moderate-Stage Retinitis Pigmentosa: Longitudinal Analysis from the Retinitis Pigmentosa Progression and Inflammatory Marker Registry Study"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2636-9250","authenticated-orcid":false,"given":"Sakurako","family":"Shimokawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaho","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Hisai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9763-5372","authenticated-orcid":false,"given":"Masatoshi","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5084-8187","authenticated-orcid":false,"given":"Kohta","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Koyanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7935-4244","authenticated-orcid":false,"given":"Shoji","family":"Notomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4590-4471","authenticated-orcid":false,"given":"Keijiro","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akie","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7938-515X","authenticated-orcid":false,"given":"Atsushi","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8329-2455","authenticated-orcid":false,"given":"Fuyuka","family":"Miyahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4926-8772","authenticated-orcid":false,"given":"Naoki","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8422-1112","authenticated-orcid":false,"given":"Yuko","family":"Kobayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4305-1660","authenticated-orcid":false,"given":"Go","family":"Mawatari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Ishizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1050-2461","authenticated-orcid":false,"given":"Tomoko","family":"Kaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh-Hei","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3761-1732","authenticated-orcid":false,"given":"Yusuke","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9549","key":"10.1016\/j.xops.2026.101381_bib1","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","article-title":"Retinitis pigmentosa","volume":"368","author":"Hartong","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.xops.2026.101381_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.preteyeres.2018.03.005","article-title":"Non-syndromic retinitis pigmentosa","volume":"66","author":"Verbakel","year":"2018","journal-title":"Prog Retin Eye Res"},{"issue":"21","key":"10.1016\/j.xops.2026.101381_bib3","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa2309915","article-title":"Gene editing for CEP290-Associated retinal degeneration","volume":"390","author":"Pierce","year":"2024","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.xops.2026.101381_bib4","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa1414221","article-title":"Long-term effect of gene therapy on Leber's congenital amaurosis","volume":"372","author":"Bainbridge","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xops.2026.101381_bib5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ajo.2024.05.034","article-title":"Phase 1\/2 AAV5-hRKp.RPGR (Botaretigene sparoparvovec) gene therapy: safety and efficacy in RPGR-Associated X-Linked retinitis pigmentosa","volume":"267","author":"Michaelides","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101381_bib6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ajo.2024.11.021","article-title":"Subretinal gene therapy drug AGTC-501 for XLRP phase 1\/2 multicenter Study (HORIZON): 24-Month safety and efficacy results","volume":"271","author":"Yang","year":"2025","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.xops.2026.101381_bib7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/08820538.2021.1887903","article-title":"Gene editing technology: towards precision medicine in inherited retinal diseases","volume":"36","author":"Ballios","year":"2021","journal-title":"Semin Ophthalmol"},{"issue":"7","key":"10.1016\/j.xops.2026.101381_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.9.7.2","article-title":"Advancing clinical trials for inherited retinal diseases: recommendations from the second Monaciano symposium","volume":"9","author":"Thompson","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"7","key":"10.1016\/j.xops.2026.101381_bib9","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/s41591-021-01351-4","article-title":"Partial recovery of visual function in a blind patient after optogenetic therapy","volume":"27","author":"Sahel","year":"2021","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.xops.2026.101381_bib10","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.stem.2023.11.004","article-title":"Safety and stable survival of stem-cell-derived retinal organoid for 2 years in patients with retinitis pigmentosa","volume":"30","author":"Hirami","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.xops.2026.101381_bib11","doi-asserted-by":"crossref","DOI":"10.1088\/1741-2552\/aa7a27","article-title":"Gene therapy for inherited retinal degenerations: initial successes and future challenges","volume":"14","author":"Gupta","year":"2017","journal-title":"J Neural Eng"},{"issue":"9","key":"10.1016\/j.xops.2026.101381_bib12","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ophtha.2024.02.023","article-title":"Assessment of visual function with cotoretigene toliparvovec in X-Linked retinitis pigmentosa in the randomized XIRIUS phase 2\/3 Study","volume":"131","author":"Lam","year":"2024","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.xops.2026.101381_bib13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s10384-023-00986-9","article-title":"A nationwide survey of newly certified visually impaired individuals in Japan for the fiscal year 2019: impact of the revision of criteria for visual impairment certification","volume":"67","author":"Matoba","year":"2023","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"10.1016\/j.xops.2026.101381_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s10384-018-0623-4","article-title":"Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals","volume":"63","author":"Morizane","year":"2019","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101381_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.100778","article-title":"Innate immune response in retinal homeostasis and inflammatory disorders","volume":"74","author":"Murakami","year":"2020","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.xops.2026.101381_bib16","article-title":"Neuroinflammation in retinitis pigmentosa: therapies targeting the innate immune system","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.xops.2026.101381_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13111935","article-title":"Neuroinflammation as a therapeutic target in Retinitis Pigmentosa and Quercetin as its potential modulator","volume":"13","author":"Ortega","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xops.2026.101381_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.911430","article-title":"Necroptosis and neuroinflammation in retinal degeneration","volume":"16","author":"Tao","year":"2022","journal-title":"Front Neurosci"},{"key":"10.1016\/j.xops.2026.101381_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154943","article-title":"Multiple cytokine analyses of aqueous humor from the patients with retinitis pigmentosa","volume":"127","author":"Lu","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.xops.2026.101381_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/srep33921","article-title":"Increased aqueous flare is associated with thickening of inner retinal layers in eyes with retinitis pigmentosa","volume":"6","author":"Nagasaka","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.xops.2026.101381_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/13816810.2024.2414081","article-title":"Genetically predicted inflammatory cytokine levels and risk of retinitis pigmentosa","volume":"46","author":"Ren","year":"2025","journal-title":"Ophthalmic Genet"},{"issue":"24","key":"10.1016\/j.xops.2026.101381_bib22","doi-asserted-by":"crossref","first-page":"8139","DOI":"10.1523\/JNEUROSCI.5200-13.2014","article-title":"Suppression of microglial activation is neuroprotective in a mouse model of human retinitis pigmentosa","volume":"34","author":"Peng","year":"2014","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.xops.2026.101381_bib23","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ajo.2015.02.001","article-title":"Relationship between aqueous flare and visual function in retinitis pigmentosa","volume":"159","author":"Murakami","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.xops.2026.101381_bib24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ophtha.2012.07.006","article-title":"Clinical evidence of sustained chronic inflammatory reaction in retinitis pigmentosa","volume":"120","author":"Yoshida","year":"2013","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.xops.2026.101381_bib25","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/bjophthalmol-2018-312225","article-title":"Correlation between aqueous flare and residual visual field area in retinitis pigmentosa","volume":"103","author":"Nishiguchi","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.xops.2026.101381_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1167\/iovs.61.8.26","article-title":"Aqueous flare and progression of visual field loss in patients with retinitis pigmentosa","volume":"61","author":"Fujiwara","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.xops.2026.101381_bib27","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1111\/aos.13502","article-title":"C-Reactive protein and progression of vision loss in retinitis pigmentosa","volume":"96","author":"Murakami","year":"2018","journal-title":"Acta Ophthalmol"},{"issue":"11","key":"10.1016\/j.xops.2026.101381_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1167\/iovs.61.11.30","article-title":"Changes of serum inflammatory molecules and their relationships with visual function in Retinitis pigmentosa","volume":"61","author":"Okita","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.xops.2026.101381_bib29","doi-asserted-by":"crossref","first-page":"pgac003","DOI":"10.1093\/pnasnexus\/pgac003","article-title":"Circulating inflammatory monocytes oppose microglia and contribute to cone cell death in retinitis pigmentosa","volume":"1","author":"Funatsu","year":"2022","journal-title":"PNAS Nexus"},{"issue":"9","key":"10.1016\/j.xops.2026.101381_bib30","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.15252\/emmm.201505298","article-title":"Microglial phagocytosis of living photoreceptors contributes to inherited retinal degeneration","volume":"7","author":"Zhao","year":"2015","journal-title":"EMBO Mol Med"},{"issue":"3","key":"10.1016\/j.xops.2026.101381_bib31","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.immuni.2019.02.007","article-title":"Microglial function is distinct in different anatomical locations during retinal homeostasis and degeneration","volume":"50","author":"O'Koren","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.xops.2026.101381_bib32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-3-031-76550-6_22","article-title":"Monocytes in retinal degeneration: little cells with a big impact","volume":"1468","author":"Ronning","year":"2025","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"10.1016\/j.xops.2026.101381_bib33","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41419-023-06350-6","article-title":"Peripheral monocytes and neutrophils promote photoreceptor cell death in an experimental retinal detachment model","volume":"14","author":"Maidana","year":"2023","journal-title":"Cell Death Dis"},{"issue":"6","key":"10.1016\/j.xops.2026.101381_bib34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tins.2020.03.012","article-title":"Microglia versus monocytes: distinct roles in degenerative diseases of the retina","volume":"43","author":"Yu","year":"2020","journal-title":"Trends Neurosci"},{"issue":"2","key":"10.1016\/j.xops.2026.101381_bib35","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4049\/jimmunol.1800982","article-title":"Microglia regulate neuroglia remodeling in various ocular and retinal injuries","volume":"202","author":"Paschalis","year":"2019","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.xops.2026.101381_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035446","article-title":"Role of fractalkine\/CX3CR1 interaction in light-induced photoreceptor degeneration through regulating retinal microglial activation and migration","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.xops.2026.101381_bib37","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1084\/jem.20190009","article-title":"C3- and CR3-dependent microglial clearance protects photoreceptors in retinitis pigmentosa","volume":"216","author":"Silverman","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/j.xops.2026.101381_bib38","article-title":"Microglia at sites of atrophy restrict the progression of retinal degeneration via Galectin-3 and Trem2 interactions","author":"Yu","year":"2023","journal-title":"bioRxiv"},{"issue":"8","key":"10.1016\/j.xops.2026.101381_bib39","first-page":"4360","article-title":"Microglia modulation by TGF-beta1 protects cones in mouse models of retinal degeneration","volume":"130","author":"Wang","year":"2020","journal-title":"J Clin Invest"},{"issue":"48","key":"10.1016\/j.xops.2026.101381_bib40","doi-asserted-by":"crossref","first-page":"E11359","DOI":"10.1073\/pnas.1807123115","article-title":"Permanent neuroglial remodeling of the retina following infiltration of CSF1R inhibition-resistant peripheral monocytes","volume":"115","author":"Paschalis","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.xops.2026.101381_bib41","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ajpath.2018.03.005","article-title":"The role of microglia and peripheral monocytes in retinal damage after corneal chemical injury","volume":"188","author":"Paschalis","year":"2018","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.xops.2026.101381_bib42","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s10384-025-01179-2","article-title":"Study protocol for a prospective natural history registry investigating the relationships between inflammatory markers and disease progression in retinitis pigmentosa: the RP-PRIMARY study","volume":"69","author":"Murakami","year":"2025","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"10.1016\/j.xops.2026.101381_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.100930","article-title":"Baseline relationships between visual function and inflammatory markers in the registry of moderated-stage retinitis pigmentosa","volume":"6","author":"Hisai","year":"2026","journal-title":"Ophthalmol Sci"},{"issue":"1","key":"10.1016\/j.xops.2026.101381_bib44","doi-asserted-by":"crossref","first-page":"8070","DOI":"10.1038\/s41598-018-26231-9","article-title":"Assessment of central visual function in patients with retinitis pigmentosa","volume":"8","author":"Fujiwara","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.xops.2026.101381_bib45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/IAE.0000000000002808","article-title":"Clinical characteristics and natural history of rho-associated retinitis pigmentosa: a long-term Follow-Up Study","volume":"41","author":"Nguyen","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.xops.2026.101381_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2024.02.005","article-title":"Genetics, clinical characteristics, and natural history of PDE6B-Associated retinal dystrophy","volume":"263","author":"Hashem","year":"2024","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.xops.2026.101381_bib47","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.oret.2024.08.018","article-title":"PDE6A-Associated retinitis pigmentosa, clinical characteristics, genetics, and natural history","volume":"9","author":"Hashem","year":"2025","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2026.101381_bib48","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ajo.2025.11.002","article-title":"Central retinal sensitivity decline in RPGR-Related retinal phenotypes","volume":"282","author":"Josan","year":"2026","journal-title":"Am J Ophthalmol"},{"issue":"15","key":"10.1016\/j.xops.2026.101381_bib49","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.167546","article-title":"Natural history of retinitis pigmentosa based on genotype, vitamin A\/E supplementation, and an electroretinogram biomarker","volume":"8","author":"Comander","year":"2023","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.xops.2026.101381_bib50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41525-025-00541-0","article-title":"Clinical characteristics of EYS-associated retinal dystrophy in 291 Japanese patients","volume":"11","author":"Koyanagi","year":"2025","journal-title":"NPJ Genom Med"},{"issue":"9","key":"10.1016\/j.xops.2026.101381_bib51","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/tvst.13.9.18","article-title":"Establishing clinical trial endpoints in selecting patients for RPGR retinal gene therapy","volume":"13","author":"Christou","year":"2024","journal-title":"Transl Vis Sci Technol"},{"issue":"3","key":"10.1016\/j.xops.2026.101381_bib52","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/bjo-2024-325323","article-title":"Long-term natural history of ellipsoid zone width in USH2A-retinopathy","volume":"109","author":"Heyang","year":"2025","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.xops.2026.101381_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/genes8070178","article-title":"EYS mutations causing autosomal recessive Retinitis pigmentosa: changes of retinal structure and function with disease progression","volume":"8","author":"McGuigan","year":"2017","journal-title":"Genes (Basel)"},{"issue":"1","key":"10.1016\/j.xops.2026.101381_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47251-z","article-title":"Multimodal structural disease progression of retinitis pigmentosa according to mode of inheritance","volume":"9","author":"Jauregui","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2026.101381_bib55","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7204954","article-title":"Progression rate of visual function and affecting factors at different stages of retinitis pigmentosa","volume":"2022","author":"Ito","year":"2022","journal-title":"Biomed Res Int"},{"issue":"8","key":"10.1016\/j.xops.2026.101381_bib56","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/tvst.13.8.18","article-title":"Ocular and serum profiles of inflammatory molecules associated with retinitis pigmentosa","volume":"13","author":"Tao","year":"2024","journal-title":"Transl Vis Sci Technol"},{"issue":"4","key":"10.1016\/j.xops.2026.101381_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22042096","article-title":"Retinal inflammation, cell death and inherited retinal dystrophies","volume":"22","author":"Olivares-Gonzalez","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.xops.2026.101381_bib58","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10792-009-9310-2","article-title":"Laser flare photometry: a noninvasive, objective, and quantitative method to measure intraocular inflammation","volume":"30","author":"Tugal-Tutkun","year":"2010","journal-title":"Int Ophthalmol"},{"issue":"6","key":"10.1016\/j.xops.2026.101381_bib59","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s004170050101","article-title":"Aqueous flare in retinitis pigmentosa","volume":"236","author":"Kuchle","year":"1998","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"15","key":"10.1016\/j.xops.2026.101381_bib60","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1167\/iovs.66.15.61","article-title":"Dynamic inner blood retina barrier disruption in Retinitis pigmentosa","volume":"66","author":"Byrne","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.xops.2026.101381_bib61","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/trf.12532","article-title":"Predicting blood loss and transfusion requirement in patients undergoing surgery for musculoskeletal tumors","volume":"54","author":"Thompson","year":"2014","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.xops.2026.101381_bib62","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2337\/dc10-1407","article-title":"Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery)","volume":"34","author":"Umpierrez","year":"2011","journal-title":"Diabetes Care"},{"issue":"5984","key":"10.1016\/j.xops.2026.101381_bib63","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.1191409","article-title":"Paleontology. Warm-blooded \"sea dragons\"?","volume":"328","author":"Motani","year":"2010","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.xops.2026.101381_bib64","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber's congenital amaurosis","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xops.2026.101381_bib65","article-title":"Protocol for NAC Attack, a phase-3, multicenter randomized, parallel, double masked, placebo controlled trial evaluating the efficacy and safety of oral N-acetylcysteine (NAC) in patients with retinitis pigmentosa","author":"Kong","year":"2025","journal-title":"medRxiv"},{"issue":"10","key":"10.1016\/j.xops.2026.101381_bib66","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1167\/tvst.13.10.15","article-title":"Endpoints and design for clinical trials in USH2A-Related retinal degeneration: results and recommendations from the RUSH2A natural history Study","volume":"13","author":"Maguire","year":"2024","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.xops.2026.101381_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103430","article-title":"Safety and efficacy of MCO-010 optogenetic therapy in patients with Stargardt disease in USA (STARLIGHT): an open-label multi-center Ph2 trial","volume":"87","author":"Lam","year":"2025","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.xops.2026.101381_bib68","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40123-012-0005-9","article-title":"Topical isopropyl unoprostone for retinitis pigmentosa: microperimetric results of the phase 2 clinical study","volume":"1","author":"Yamamoto","year":"2012","journal-title":"Ophthalmol Ther"},{"issue":"6","key":"10.1016\/j.xops.2026.101381_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2024.100582","article-title":"Comparison of microperimetry and static perimetry for evaluating macular function and progression in Retinitis pigmentosa","volume":"4","author":"Fukushima","year":"2024","journal-title":"Ophthalmol Sci"},{"issue":"3","key":"10.1016\/j.xops.2026.101381_bib70","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1111\/aos.12293","article-title":"Therapeutic efficacy of topical unoprostone isopropyl in retinitis pigmentosa","volume":"92","author":"Akiyama","year":"2014","journal-title":"Acta Ophthalmol"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526003192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526003192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:36:57Z","timestamp":1790253417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914526003192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":70,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2666914526003192"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2026.101381","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory Markers and Disease Progression in Moderate-Stage Retinitis Pigmentosa: Longitudinal Analysis from the Retinitis Pigmentosa Progression and Inflammatory Marker Registry Study","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2026.101381","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101381"}}